May 9, 2025 | Federal Government Asks 11th Circuit To Reverse Decision Declaring Qui Tam Provision of the False Claims Act Unconstitutional

In October 2024, we wrote about U.S. District Judge Kathryn Kimball Mizelle’s dismissal of a whistleblower action, deeming the qui tam provisions of the False Claims Act (FCA) unconstitutional.1 The Department of Justice (DOJ) intervened on appeal...

May 9, 2025 | FTC Finalizes Updates to COPPA Rule: What You Need To Know

On April 22, 2025, the Federal Trade Commission (FTC) published final updates to the Children’s Online Privacy Protection Act Rule (COPPA Rule). The final COPPA Rule goes into effect on June 23, 2025, 60 days after its publication; however, regula...

May 8, 2025 | Lowenstein Represents Inductive Bio in $25M Series A Financing to Transform Small Molecule Drug Discovery with Industry-Wide AI Platform

Lowenstein Sandler represented Inductive Bio in $25 million Series A financing to transform small molecule drug discovery with an industry-wide AI platform. Obvious Ventures led the funding round with participation from Andreessen Horowitz (a16z)...

May 8, 2025 | Lowenstein Center for the Public Interest Announces Publication of Latest Pro Bono Report

Lowenstein Sandler and its Center for the Public Interest have announced the release of their latest Pro Bono Report, detailing the firm’s pro bono efforts throughout 2024. The firm’s lawyers devoted more than 29,000 hours to pro bono service over...

May 8, 2025

2024 Pro Bono Report

The 2024 Pro Bono Report details the firm’s pro bono efforts through the Lowenstein Center for the Public Interest last year, with the firm’s lawyers devoting more than 29,000 hours to pro bono service in 2024. Some of the many ways Lowenstein’s l...